Marie Jauffret-Roustide is Researcher at the National Institute of Health and Medical Research since 2014.
She has obtained a PhD in Sociology and Social Science at Paris XI University in 2010 and a Master Degree in Political Science and Public policy Analysis, at Sciences Po in 1996.
She has worked as a scientific coordinator of HIV and HCV surveillance among drug users at the National Institute for Public Health Surveillance (InVS) (2003-2013) and she is still now an associate Researcher at InVS.
She leads epidemiological and sociological studies on drug use practices and social processes of at-risk practices and sero-epidemiological studies among drug-users (people who inject drugs, crack users, …).
She is also involved in public policy analysis, on sociological and historical aspects on harm reduction policies at a national and international level.
Marie Jauffret-Roustide is the principal co-investigator of Cosinus cohort since 2014 and the principal investigator of a national cross-sectional study (called ANRS Coquelicot Study) on HIV and HCV seroprevalence and at-risk practices among drug users since 2003. ANRS-Coquelicot study documented the positive impact of the french harm reduction model on HIV combined to a limited impact on HCV in France. She also coordonates a community based interventional trials on HCV transmission among crack users between 2009 and 2014.
She has published on the epidemiology of HIV and HCV, on the social acceptance of harm reduction policies, on the history of self-support groups of drug users and on methodological aspects of research on drug users (time location sampling studies, modelling studies, qualitative research, community based research and interventional trials, social network studies, respondent driven sampling, …).
She is now the leader of an international comparative research project on harm reduction policies including the analysis of the biomedicalization process of addiction, the history of peer education and community based approaches and the impact of repression on at-risk practices among drug-users.